NASDAQ : HSCS
HeartSciences Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 3.61 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 17.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 15.89M |
| Enterprise Value | 19.86M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 14, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 4.80M |
| Shares Outstanding | 4.80M |
| Shares Change (YoY) | +200.72% |
| Shares Change (QoQ) | +16.78% |
| Owned by Insiders (%) | 18.17% |
| Owned by Institutions (%) | 6.88% |
| Float | 3.39M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3,515.95 |
| Forward PS | 244.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4,395.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.14 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -1,851.90% |
| Return on Assets (ROA) | -116.44% |
| Return on Invested Capital (ROIC) | -167.82% |
| Return on Capital Employed (ROCE) | 499.92% |
| Weighted Average Cost of Capital (WACC) | 14.39% |
| Revenue Per Employee | $323 |
| Profits Per Employee | -$732,802 |
| Employee Count | 14 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.00 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.78 |
| 52-Week Price Change | +11.45% |
| 50-Day Moving Average | 3.61 |
| 200-Day Moving Average | 2.72 |
| Relative Strength Index (RSI) | 47.70 |
| Average Volume (20 Days) | 120,347 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 63,146 |
| Short Previous Month | 27,931 |
| Short % of Shares Out | 1.32% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 0.26 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4,519 |
| Gross Profit | 2,751 |
| Operating Income | -9.48M |
| Pretax Income | -10.26M |
| Net Income | -10.26M |
| EBITDA | -9.45M |
| EBIT | -9.48M |
| Loss Per Share | -$3.19 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 29,906 |
| Total Debt | 4.00M |
| Net Cash | -3.97M |
| Net Cash Per Share | -$0.83 |
| Equity (Book Value) | -2.03M |
| Book Value Per Share | -0.52 |
| Working Capital | -4.82M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -6.79M |
| Capital Expenditures | -3,554 |
| Depreciation & Amortization | 27,012 |
| Net Borrowing | 2.42M |
| Free Cash Flow | -6.80M |
| FCF Per Share | -$1.42 |
Margins
| Measure | Value |
|---|
| Gross Margin | 60.88% |
| Operating Margin | -209,733.08% |
| Pretax Margin | -227,024.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -200.72% |
| Shareholder Yield | -200.72% |
| Earnings Yield | -96.35% |
| FCF Yield | -42.77% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 3,680.42% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -42.17 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |